Posts Tagged ‘nasdaq’

Microsoft Corp. (MSFT) – Buzz Stock of the Day

Thursday, October 28th, 2010

Software giant Microsoft Corp. (Nasdaq: MSFT) reported strong profit and sales growth in its first fiscal quarter, driven largely by sales of its flagship Windows and Office software and the launch of the latest blockbuster Halo video game.

For its first fiscal quarter ended September 30, 2010, Microsoft reported EPS of 62 cents. Analysts on average were expecting earnings of 55 cents per share, according to Thomson Reuters. Operating income, and  net income a the quarter were $7.12 billion, $5.41 billion, which represented increases of 59 percent and 51 percent  respectively, when compared with the prior year period. Sales increased 25 percent to $16.2 billion, ahead of analysts’ $15.8 billion average estimates.
[–quote–]
“This was an exceptional quarter, combining solid enterprise growth and continued strong consumer demand for Office 2010, Windows 7, and Xbox 360 consoles and games,” said Peter Klein, chief financial officer at Microsoft in a statement. “Our ability to grow revenue while continuing to control costs allowed us to deliver another quarter of year-over-year margin expansion.”

Among the highlights were a 15 percent sales growth in Microsoft’s Office 2010 software, and a 38 percent increase in sales of Microsoft’s Xbox 360 game console.

“We ended up in this great sweet spot in business spending that was re-emerging after the downturn,” Microsoft’s general manager of investor relations, Bill Koefoed, said in an interview. Increased business spending “aligned just perfectly” with Microsoft’s product launches, according to Koefoed.

Revenue from Microsoft’s Windows division increased 66 percent to $4.8 billion. Office and other business software brought in $5.1 billion, a 14 percent jump, over last year. The group that makes server software reported a 12 percent increase in revenue to $4 billion. Microsoft’s online revenue, which comes primarily from search advertising,  was up  8 percent to $527 million.

The company reaffirmed its operating expense guidance of $26.9 billion to $27.3 billion for the full year ending June 30, 2011.

Mid Day Market Movers (LIFE, UHN, ABT)

Wednesday, October 27th, 2010

Life Technologies Corporation (Nasdaq: LIFE) jumped more than 6 percent  to $50.66 from yesterday’s closing price of 47.79, with more than double average volume. The maker of biotech tools reported quarterly net income of $105.5 million, or 56 cents a share, on revenue of $867.1 million, besting analysts’ predictions of 78 cents a share on revenue of $855.2 million. The company also forecast full-year adjusted earnings of $3.48 to $3.52 a share, compared with a Street consensus of $3.42 a share on Tuesday.

UnitedHealth Group Incorporated (NYSE: UNH) dropped more than 5 percent Wednesday touching on a low of $35.70 from the previous days’ close of $37.57 on above-average volume. The stock is still trading very near a 52-week high of $37.95. The company recently reported third quarter increase in net income of 23%, to $1.28 billion, or $1.14 per share, from $1.04 billion, or 89 cents per share, from the same period last year.

Abbott Laboratories (NYSE: ABT) dipped nearly 3 percent trading on below-average volume, touching on a low of 51.03 from Tuesday’s close of $52.69. The Company recently reported strong third quarter results, notably; earnings-per-share growth of 14.1 percent, worldwide sales increase of 11.8 percent, and promising expansion in emerging markets.

AspenBio Pharma, Inc. (APPY) – Buzz Stock of the Day

Tuesday, October 26th, 2010

Shares of diagnostic products maker, AspenBio Pharma, Inc. (Nasdaq: APPY) were up as much as 71 percent from Monday’s closing price, in morning trading on Tuesday after the company announced that it initiated manufacturing on its AppyScore™ cassette-based test system, and added personnel to handle its clinical, regulatory and commercial planning efforts.

“Aspen has made significant progress advancing the AppyScore cassette-based test and we are excited to put the test in the hands of actual hospital users for feedback as we proceed towards our pivotal clinical trial,” said Steve Lundy, President and Chief Executive Officer in a statement.
[–quote–]
AppyScore™ is a rapid, blood-based test designed to assist doctors in assessing the low risk population of emergency room patients suspected of having acute appendicitis when presenting with abdominal pain.

According to AspenBio’s Web site, up to 18% of patients are misdiagnosed and sent home with appendicitis; 8 – 10% of surgeries remove a normal appendix; women are more difficult to diagnose than men and the negative appendectomy rate is significantly higher in women; an estimated 1 million patients present annually with a low risk for acute appendicitis and are exposed to unnecessary CT scan radiation—a potentially significant health risk.

The Colorado-based company also appointed Michael Wandell, PharmD to lead its human diagnostic products’ clinical and regulatory strategy, and Erik Miller to head the company’s commercial planning efforts, including pre-clinical field testing of the AppyScore system.

Shares of AspenBio Pharma, Inc. are up about 44 percent since October 1.

Notable Nasdaq Gainers – APPY, MIPS, SUPG, MCOX

Tuesday, October 26th, 2010

AspenBio Pharma, Inc. (Nasdaq: APPY) shares are up more than 125 percent since October 18th. Shares opened this morning at $0.60 and surged as high as $0.98. The company issued a news release this morning before the opening bell announcing that it has initiated manufacturing of its AppyScore™ cassette-based test system to be used in further validation and verification testing. AppyScore is a blood-based diagnostic test designed to aid emergency department physicians in the difficult challenge of evaluating patients suspected of having appendicitis. AspenBio Pharma also announced that it has contracted with Michael Wandell, PharmD to lead its human diagnostic products’ clinical and regulatory strategy, and Erik Miller to spearhead the company’s commercial planning efforts.

MIPS Technologies, Inc. (Nasdaq: MIPS) shares increased almost 24 percent from Monday’s closing price in morning trading on Tuesday after the chip maker announced first quarter  profit of  $7.6 million, or 16 cents per share, compared with $595,000, or a penny per share, a year earlier. Excluding one-time items, MIPS earned 17 cents per share. Analysts polled by Thomson Reuters expected earnings of  7 cents per share. MIPS Technologies’ quarterly revenue jumped 50 percent to $22.5 million, largely driven by a big jump in royalties revenue. Analysts expected $19.7 million in revenue. Shares of MIPS are up about 113 percent over the past 12-months.

SuperGen, Inc. (Nasdaq: SUPG) shares were up as much as 27 percent from Monday’s closing price in morning trading on Tuesday, after the oncology-focused biotech company announced better-than-expected third-quarter profit, driven by by royalty revenue from its blood cancer drug, Dacogen. Third-quarter net income increased  to $3.9 million, or 6 cents a share, from $833,000 or 1 cent a share, a year ago. Revenue in the quarter rose 29 percent to $13.4 million. Royalty revenue from Dacogen rose was up $2.8 million to $13.2 million. Analysts on an average were expecting a loss of a penny per share on revenue of $11.18 million. SuperGen also raised its outlook for 2010. The company expects full-year profit of less than $12 million, up from its previous estimate of less than $4.5 million. SuperGen expects royalty revenue from Dacogen to be between $49 million and $52 million, up from its previously estimated range of $44 million to $48 million.

Mecox Lane Limited (Nasdaq: MCOX) shares had a great debut on Tuesday, opening nearly 60 percent above its initial public offering price. Mecox, which sells clothing and accessories to young  women, sold 11.74 million American Depositary Shares for $11 each, raising about $129.17 million. Shares soared as high as $18.50 in morning trading on Tuesday. Credit Suisse Securities (USA) LLC and UBS AG acted as joint bookrunners for the offering. Oppenheimer & Co. Inc. and Roth Capital Partners, LLC acted as co-managers for the offering. Mecox Lane’s website, M18.com, sells proprietary brands including Euromoda and Rampage, and well-known third party brands including Adidas and Daphne. The company had about 2.1 million active online customers as of June 30. For the six months ended June 30, Mecox Lane posted net revenue of $108.03 million, up 41.6 percent from a year earlier. Net income for the same period fell 37.7 percent to $2.53 million, from a year earlier.

Sohu.com, Inc. (SOHU) – Buzz Stock of the Day

Monday, October 25th, 2010

Sohu.com, Inc. (Nasdaq: SOHU)Shares of Chinese Web portal Sohu.com, Inc. (Nasdaq: SOHU) touched a new 52-week high on Monday after the company announced third quarter results that soundly beat the Street’s estimates. The improved results were primarily driven by revenue growth in the company’s online gaming segment.  Other contributing factors included a 134 percent increase in the company’s paid search revenue and an 22 percent increase in Sohu’s advertising revenue, over the same period last year.
[–quote–]
“Our largest business segment, online games, powered by the successful release of new expansion packs for our proprietary flagship product and the launch of new licensed games, once again achieved solid results,” said Sohu’s Chairman and CEO Dr. Charles Zhang in a statement.

“Our brand advertising business also set new records in the third quarter,” said Sohu’s Co-President and Chief Operating Officer Belinda Wang in a statement. “Our expanding group of advertising partners is taking advantage of strong economic conditions in China along with particular strength in each of their end markets.  More specifically, they are looking to us to help maximize their advertising spending based on our significant investments in our online platform and other value-added solutions.”

Sohu’s quarterly profit increased to $38.7 million, or $1.01 a share, from $34.4 million, or 88 cents, a year earlier. Year-over-year, Sohu’s total revenue increased 20 percent to a record, $164.1 million, well above analysts’ estimates of $156.7 million. Revenue from the company’s online gaming segment, which comprises more than half of  its total revenue, increased 25 percent to $85.6 million, over the same period last year.

Sohu forecast revenue of between $163 million and $168 million for the current quarter, versus $162.58 million expected; profit per share, excluding some costs, is projected at $1.10 to $1.15, versus the 95 cent average estimate.

The online gaming segment, powered by Changyou.com Ltd. (Nasdaq: CYOU)  has three more in-house games under development and they plan to launch one every quarter, according to Think Equity analyst Atul Bagga.

Changyou also just reported a record quarter with $85.6 million in sales, and $45.3 million in profit, up 25 percent, and 20 percent respectively, over the same period last year.